🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this pilot research study is to test whether certain compone...
Status
Completed
Location
New York State Psychiatric Institute
Start Date
2017-10-01
Trial ID
NCT03274440
This is a multi-center, open-label study to assess the efficacy and safety ...
Status
Completed
Location
University of South Florida
Start Date
2008-05
Trial ID
NCT00634569
Treatments Being Tested
The goal of this randomised, double-blind phase II/III clinical trial is to...
Status
Completed
Location
Exalt Clinical Research
Start Date
2024-05-02
Trial ID
NCT06146101
Treatments Being Tested
A subset of heavy marijuana users have trouble quitting marijuana use and t...
Status
Completed
Location
Behavioral Pharmacology Research Unit
Start Date
2009-04
Trial ID
NCT00893074
Treatments Being Tested
This is a pilot clinical trial of dronabinol to treat disabling attacks of ...
Status
Withdrawn
Location
NYU Medical Center
Start Date
2015-11
Trial ID
NCT02608931
Treatments Being Tested
This study will assess the analgesic, appetite-stimulating, and subjective ...
Status
Active Not Recruiting
Location
University of California, Los Angeles
Start Date
2023-02-15
Trial ID
NCT04859296
The goal of this open-label, placebo-controlled, dosage escalation study is...
Status
Completed
Location
University of Regina
Start Date
2024-02-15
Trial ID
NCT06204003
Treatments Being Tested
Persistent postsurgical abdominal pain (PPAP) is a very difficult to treat ...
Status
Completed
Location
Radboud University Nijmegen Medical Centre
Start Date
2012-10
Trial ID
NCT01562483
Treatments Being Tested
This clinical trial is being done to better understand how daily treatment ...
Status
Recruiting
Location
University of Michigan
Start Date
2022-02-22
Trial ID
NCT04992624
Glaucoma is among the leading causes for irreversible blindness worldwide. ...
Status
Completed
Location
Department of Clinical Pharmacology, Medical University Vienna
Start Date
2020-11-11
Trial ID
NCT04596826
Treatments Being Tested